Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib for Radiation Pneumonitis Prophylaxis in NSCLC
NCT02452463Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jun 2015
- Primary completion
- Jun 2019
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib in radiation-induced pneumonitis (RP), sponsored by Roswell Park Comprehensive Cancer Center. Started Jun 2015; status: terminated.
02
Drugs
nintedanib
03
Conditions
radiation-induced pneumonitis (RP)
Beyond the preview
Go deeper on NCT02452463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452463.